v3 Template
D

DelSiTech

Biotechnology / Pharmaceutical ~300 employees
Founded
--
Employees (Est.)
~300
15 leaders known
Total Funding
$10.9M
Funding Rounds
1
Last Funding
2024-01-16

About DelSiTech

DelSiTech is a technology platform company specializing in long-acting formulations, dedicated to transforming the treatment landscape in metabolic disease and pain management through innovative silica-based biodegradable drug delivery systems. Their mission is to improve patient adherence and reduce dosing frequency with long-acting injectables, supporting better therapeutic outcomes and sustainability by reducing medical waste.

Products & Services

Silica Matrix Technology Platform:A versatile drug delivery system compatible with small molecules, peptides, and large biologics, formulated to release drugs over days, weeks, or months for long-lasting treatment options.
Long-Acting Injectables:Innovative solutions designed to provide sustained drug release, targeting improved patient outcomes in areas like metabolic disease and pain management.
Pipeline Products:A range of transformative long-acting injectable products under development to deliver lasting relief to patients globally.

Specialties

Long-Acting Injectables Drug Delivery Systems Silica-Based Biodegradable Technology Metabolic Disease Treatment Pain Management Solutions

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Venture Round
T: -
FT: Venture Round
A: 10870000
MR: -
FA: EUR 10 million
FAN: 10870000
D: 2024-01-16
FD: 2024-01-16
2 investors
Venture Round Latest
2024-01-16
$10.9M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

E

Essi Nevo

A

Aleksi Leino

M

Marcus Reay

O

Outi Heikkilä

Chief Operations Officer

C

Carl-Åke Carlsson

Chief Executive Officer

Ö

Örjan Andersson

Chairman of the Board

View 12 more team members with Pro

Unlock Full Team Directory

Recent News

DelSiTech Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceutical
Company Size
~300 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro